biotech
biotech Articles
Biotechnology company Equillium has amended its filing with the SEC regarding its initial public offering.
Published:
Last Updated:
GW Pharmaceuticals shares made a solid gain on Thursday after it received a critical update from the DEA.
Published:
Last Updated:
Protagonist Therapeutics shares made a solid gain on Thursday after the company announced a key update from the FDA.
Published:
Last Updated:
Geron shares were absolutely crushed on Thursday morning after it was announced that Janssen Biotech has terminated the 2014 collaboration and license agreement with the firm.
Published:
Last Updated:
Verastem shares saw a handy gain on Wednesday after the company set an exclusive licensing agreement to develop and commercialize Copiktra.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Akcea and Ionis Pharmaceuticals shares made a solid gain on Monday after the companies announced positive top-line data for a midstage trial in patients with established cardiovascular disease and...
Published:
Last Updated:
Clinical-stage biopharmaceutical company Kodiak Sciences expects to price 9 million shares for an initial public company valued up to more than $155 million.
Published:
Last Updated:
There is one fairly new effort for drug companies to mitigate the threat of generic drugs and for biotech companies to mitigate the threat of biosimilars. They can just launch their own. Several...
Published:
Last Updated:
Jefferies highlights the firm's top growth stocks to buy each week, and recently four top biotech stocks made the cut. They all make good sense now, and all have outstanding upside potential.
Published:
Last Updated:
Amarin shares absolutely skyrocketed on Monday after the company announced topline results from the Vascepa cardiovascular (CV) outcomes trial, REDUCE-IT. Needless to say, the results were very...
Published:
Last Updated:
Acadia Pharmaceuticals shares popped after the company announced that the FDA completed a postmarketing review and issued a clear statement reaffirming the positive benefit-risk profile of Nuplazid...
Published:
Last Updated:
Friday's trading session showed Novavax on the leaderboard after an analyst upgrade from JPMorgan.
Published:
Last Updated:
GTx shares were absolutely crushed on Friday after the company announced results from its mid-stage trial in post-menopausal women with stress urinary incontinence.
Published:
Last Updated:
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
Published:
Last Updated: